- Home
- STRO vs PGP Comparison
STRO vs PGP Comparison
Compare STRO & PGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- PGP
- Stock Information
- Founded
- STRO 2003
- PGP 2003
- Country
- STRO United States
- PGP United States
- Employees
- STRO N/A
- PGP N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- PGP Finance Companies
- Sector
- STRO Health Care
- PGP Finance
- Exchange
- STRO Nasdaq
- PGP Nasdaq
- Market Cap
- STRO 77.7M
- PGP 82.7M
- IPO Year
- STRO 2018
- PGP N/A
- Fundamental
- Price
- STRO $0.76
- PGP $8.31
- Analyst Decision
- STRO Hold
- PGP
- Analyst Count
- STRO 7
- PGP 0
- Target Price
- STRO $3.97
- PGP N/A
- AVG Volume (30 Days)
- STRO 1.4M
- PGP 39.8K
- Earning Date
- STRO 08-12-2025
- PGP 01-01-0001
- Dividend Yield
- STRO N/A
- PGP 10.84%
- EPS Growth
- STRO N/A
- PGP N/A
- EPS
- STRO N/A
- PGP N/A
- Revenue
- STRO $66,434,000.00
- PGP N/A
- Revenue This Year
- STRO N/A
- PGP N/A
- Revenue Next Year
- STRO N/A
- PGP N/A
- P/E Ratio
- STRO N/A
- PGP N/A
- Revenue Growth
- STRO N/A
- PGP N/A
- 52 Week Low
- STRO $0.52
- PGP $5.83
- 52 Week High
- STRO $5.17
- PGP $7.81
- Technical
- Relative Strength Index (RSI)
- STRO 44.92
- PGP 66.43
- Support Level
- STRO $0.67
- PGP $7.92
- Resistance Level
- STRO $0.79
- PGP $8.33
- Average True Range (ATR)
- STRO 0.07
- PGP 0.09
- MACD
- STRO -0.01
- PGP 0.02
- Stochastic Oscillator
- STRO 34.52
- PGP 84.44
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About PGP Pimco Global StocksPlus & Income Fund of Beneficial Interest
PIMCO Global Stocksplus & Income Fund is a closed-end management investment company. The objective of the fund is to seek a total return comprised of current income, current gains, and long-term capital appreciation. The fund invests a majority of the fund's net assets in a combination of securities and instruments that provide exposure to stocks and or produce income.